| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.0099 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0019 | 1 |